How Janssen/HealthiVibe’s Program Found The Right Messages To Improve Trial Diversity
Working with pharmacies was a key part of the Research Includes Me initiative. The experience also showed that listening to focus groups helped J&J provide the right education around clinical trial enrollment to reach and reassure minority communities.
You may also be interested in...
Company strategies at improving diversity, equity and inclusion both within their organizations and in the clinical trials they conduct have differed, but building trust is a common theme.
Novavax’s Lisa Dunkle talked to Scrip about the time and effort that went into building trust among Native American communities to encourage participation in its COVID-19 vaccine study.
Beam Therapeutics also announced that it dosed the first patient in its Phase I/II sickle cell disease trial; Vyne stepped into the increasingly competitive vitiligo space, while Tracon moved further into sarcomas in its checkpoint inhibitor program, and Telix started a small trial of its drug in brain cancer.